Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y T Tai

Showing results (121-130 of 134) with videos related to

Pageof 14
Sort By:
Blood|October 26, 2000
Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapyT Hideshima, D Chauhan, Y Shima, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 29, 1999
A prospective study of elective stenting in unprotected left main coronary diseaseP Wong, V Wong, K K Tse, et al.
Blood|July 4, 2001
Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migrationK Podar, Y T Tai, F E Davies, et al.
Leukemia|October 22, 2024
Retraction Note: SAR650984 directly induces multiple myeloma cell death via lysosomal-associated and apoptotic pathways, which is further enhanced by pomalidomideH Jiang, C Acharya, G An, et al.
Leukemia|September 5, 2015
SAR650984 directly induces multiple myeloma cell death via lysosomal-associated and apoptotic pathways, which is further enhanced by pomalidomideH Jiang, C Acharya, G An, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2006
Mast cells in Waldenstrom's macroglobulinemia support lymphoplasmacytic cell growth through CD154/CD40 signalingO Tournilhac, D D Santos, L Xu, et al.
Leukemia|November 22, 2017
Protein arginine methyltransferase 5 has prognostic relevance and is a druggable target in multiple myelomaA Gullà, T Hideshima, G Bianchi, et al.
Blood|October 26, 2000
Elevated soluble MUC1 levels and decreased anti-MUC1 antibody levels in patients with multiple myelomaS P Treon, P Maimonis, D Bua, et al.
Leukemia|October 14, 2014
Anti-tumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myelomaR Suzuki, T Hideshima, N Mimura, et al.
Leukemia|December 26, 2001
Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applicationsD Gupta, S P Treon, Y Shima, et al.
Pageof 14

Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
Blood|October 26, 2000
Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapyT Hideshima, D Chauhan, Y Shima, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 29, 1999
A prospective study of elective stenting in unprotected left main coronary diseaseP Wong, V Wong, K K Tse, et al.
Blood|July 4, 2001
Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migrationK Podar, Y T Tai, F E Davies, et al.
Leukemia|October 22, 2024
Retraction Note: SAR650984 directly induces multiple myeloma cell death via lysosomal-associated and apoptotic pathways, which is further enhanced by pomalidomideH Jiang, C Acharya, G An, et al.
Leukemia|September 5, 2015
SAR650984 directly induces multiple myeloma cell death via lysosomal-associated and apoptotic pathways, which is further enhanced by pomalidomideH Jiang, C Acharya, G An, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2006
Mast cells in Waldenstrom's macroglobulinemia support lymphoplasmacytic cell growth through CD154/CD40 signalingO Tournilhac, D D Santos, L Xu, et al.
Leukemia|November 22, 2017
Protein arginine methyltransferase 5 has prognostic relevance and is a druggable target in multiple myelomaA Gullà, T Hideshima, G Bianchi, et al.
Blood|October 26, 2000
Elevated soluble MUC1 levels and decreased anti-MUC1 antibody levels in patients with multiple myelomaS P Treon, P Maimonis, D Bua, et al.
Leukemia|October 14, 2014
Anti-tumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myelomaR Suzuki, T Hideshima, N Mimura, et al.
Leukemia|December 26, 2001
Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applicationsD Gupta, S P Treon, Y Shima, et al.
Pageof 14